Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy of QingyiHuaji Optimized Formula Combined With Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer: a Prospective, Multicenter, Randomized Controlled Clinical Study

NCT05840341 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT05840341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05840341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy of QingyiHuaji Optimized Formula Combined With Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer: a Prospective, Multicenter, Randomized Controlled Clinical Study
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Completed
Start date
April 17, 2023
Completion date
December 30, 2025
Enrollment
305 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic neoplasms